UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface

Cancer immunology research, 2018-08, Vol.6 (8), p.921-929

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhancing SIV-specific immunity in vivo by PD-1 blockade

Nature, 2009-03, Vol.458 (7235), p.206-210

2009

Link zum Volltext

Verfügbarkeit prüfen

Restoring function in exhausted CD8 T cells during chronic viral infection

Nature, 2006-02, Vol.439 (7077), p.682-687

2006

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (37), p.15001-15006

2013

Link zum Volltext

Verfügbarkeit prüfen

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Nature, 2006-09, Vol.443 (7109), p.350-354

2006

Link zum Volltext

Verfügbarkeit prüfen

In-Fusion™ assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutations

BioTechniques, 2007-09, Vol.43 (3), p.354-359

2007

Link zum Volltext

Verfügbarkeit prüfen

TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells

Immunity (Cambridge, Mass.), 2007-12, Vol.27 (6), p.927-940

2007

Link zum Volltext

Verfügbarkeit prüfen

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival

PloS one, 2013-04, Vol.8 (4), p.e60391-e60391

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2600: Development of TCR-stimulating 300.19 and 300.19-hB7-1 cells using modified anti-CD3 scFv constructs

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2600-2600

2020

Link zum Volltext

Verfügbarkeit prüfen

RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance

The Journal of experimental medicine, 2014-05, Vol.211 (5), p.943-959

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 926: Binding of the novel inhibitory receptor KIR-X to its ligand HHLA2 negatively regulates T cell activation

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.926-926

2020

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Signaling triggered by engagement of PD-1 by PD-L1

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.78-78.24

2020

Link zum Volltext

Verfügbarkeit prüfen

CD160 inhibits activation of human CD4 + T cells through interaction with herpesvirus entry mediator

Nature immunology, 2008-02, Vol.9 (2), p.176-185

2008

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 binds with B7-1 only in cis on the same cell surface

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.154-154.11

2017

Link zum Volltext

Verfügbarkeit prüfen

A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.421-432

2019

Link zum Volltext

Verfügbarkeit prüfen

KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Cancer immunology research, 2021-02, Vol.9 (2), p.156-169

2021

Link zum Volltext

Verfügbarkeit prüfen

Upregulation of CTLA-4 by HIV-specific CD4 + T cells correlates with disease progression and defines a reversible immune dysfunction

Nature immunology, 2007-11, Vol.8 (11), p.1246-1254

2007

Link zum Volltext

Verfügbarkeit prüfen

Monitoring PD-1 Signaling in Tumor Infiltrating Lymphocytes

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.195-195.31

2019

Link zum Volltext

Verfügbarkeit prüfen

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Cancer immunology research, 2021-12, Vol.9 (12), p.1465-1475

2021

Link zum Volltext

Verfügbarkeit prüfen

Monitoring PD-1 phosphorylation to evaluate PD-1 signaling during anti-tumor immune responses

Cancer immunology research, 2021-10

2021

Link zum Volltext

Verfügbarkeit prüfen

RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance (IRC5P.465)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.125-125.14

2014

Link zum Volltext

Verfügbarkeit prüfen

TIM-4 mediated phagocytosis of apoptotic cells induces regulatory cytokine secretion by mouse peritoneal macrophages (136.47)

The Journal of immunology (1950), 2010-04, Vol.184 (1_Supplement), p.136-136.47

2010

Link zum Volltext

Verfügbarkeit prüfen

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

Cancer Immunology, Immunotherapy, 2013-02, Vol.62 (2), p.347-357

2013

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: CD160 inhibits activation of human CD4 + T cells through interaction with herpesvirus entry mediator

Nature immunology, 2008-05, Vol.9 (5), p.567-567

2008

Link zum Volltext

Verfügbarkeit prüfen

Erratum: Corrigendum: CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator

Nature immunology, 2008-05, Vol.9 (5), p.567-567

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface

Enhancing SIV-specific immunity in vivo by PD-1 blockade

Restoring function in exhausted CD8 T cells during chronic viral infection

Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

In-Fusion™ assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutations

TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival

Abstract 2600: Development of TCR-stimulating 300.19 and 300.19-hB7-1 cells using modified anti-CD3 scFv constructs

RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance

Abstract 926: Binding of the novel inhibitory receptor KIR-X to its ligand HHLA2 negatively regulates T cell activation

Intracellular Signaling triggered by engagement of PD-1 by PD-L1

CD160 inhibits activation of human CD4 + T cells through interaction with herpesvirus entry mediator

PD-L1 binds with B7-1 only in cis on the same cell surface

A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression

KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Upregulation of CTLA-4 by HIV-specific CD4 + T cells correlates with disease progression and defines a reversible immune dysfunction

Monitoring PD-1 Signaling in Tumor Infiltrating Lymphocytes

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Monitoring PD-1 phosphorylation to evaluate PD-1 signaling during anti-tumor immune responses

RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance (IRC5P.465)

TIM-4 mediated phagocytosis of apoptotic cells induces regulatory cytokine secretion by mouse peritoneal macrophages (136.47)

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

Corrigendum: CD160 inhibits activation of human CD4 + T cells through interaction with herpesvirus entry mediator

Erratum: Corrigendum: CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator

Suchergebnisse filtern